Design and Synthesis of an orally active GPIIb/IIIa antagonist based on a phenylpiperazine scaffold
作者:Jan H van Maarseveen、Jack A.J den Hartog、Koos Tipker、Jan-Hendrik Reinders、Joost Brakkee、Uwe Schön、Wolfgang Kehrbach、Chris G Kruse
DOI:10.1016/s0960-894x(98)00257-1
日期:1998.6
The design and synthesis of an orally active LMW non-peptide GPIIb/IIIa antagonist, based on a N,N'-bisphenylpiperazine scaffold, is described. The optimal compound showed a high in vitro binding potency (pIC50 = 8.7) in combination with potent oral antithrombotic activity (30-40% inhibition of thrombus growth at 0.3-3 mg/kg) with a duration of action of > 90 min. in a hamster cheek pouch model.
描述了基于N,N'-双苯基哌嗪骨架的口服活性LMW非肽GPIIb / IIIa拮抗剂的设计和合成。最佳化合物显示出高的体外结合效能(pIC50 = 8.7),并具有有效的口服抗血栓形成活性(在0.3-3 mg / kg时血栓生长抑制30-40%),作用时间> 90分钟。在仓鼠脸袋模型中。